Activin-A and Bmp4 Levels Modulate Cell Type Specification during CHIR-Induced Cardiomyogenesis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The use of human pluripotent cell progeny for cardiac disease modeling, drug testing and therapeutics requires the ability to efficiently induce pluripotent cells into the cardiomyogenic lineage. Although direct activation of the Activin-A and/or Bmp pathways with growth factors yields context-dependent success, recent studies have shown that induction of Wnt signaling using low molecular weight molecules such as CHIR, which in turn induces the Activin-A and Bmp pathways, is widely effective. To further enhance the reproducibility of CHIR-induced cardiomyogenesis, and to ultimately promote myocyte maturation, we are using exogenous growth factors to optimize cardiomyogenic signaling downstream of CHIR induction. As indicated by RNA-seq, induction with CHIR during Day 1 (Days 0-1) was followed by immediate expression of Nodal ligands and receptors, followed later by Bmp ligands and receptors. Co-induction with CHIR and high levels of the Nodal mimetic Activin-A (50-100 ng/ml) during Day 0-1 efficiently induced definitive endoderm, whereas CHIR supplemented with Activin-A at low levels (10 ng/ml) consistently improved cardiomyogenic efficiency, even when CHIR alone was ineffective. Moreover, co-induction using CHIR and low levels of Activin-A apparently increased the rate of cardiomyogenesis, as indicated by the initial appearance of rhythmically beating cells by Day 6 instead of Day 8. By contrast, co-induction with CHIR plus low levels (3-10 ng/ml) of Bmp4 during Day 0-1 consistently and strongly inhibited cardiomyogenesis. These findings, which demonstrate that cardiomyogenic efficacy is improved by optimizing levels of CHIR-induced growth factors when applied in accord with their sequence of endogenous expression, are consistent with the idea that Nodal (Activin-A) levels toggle the entry of cells into the endodermal or mesodermal lineages, while Bmp levels regulate subsequent allocation into mesodermal cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These growth factors lead to the induction of cardiac mesoderm in the embryo70 and established differentiation protocols using them show effective differentiation to various cardiac mesoderm progenitors23,70,71.”
From Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease (2021) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206 · cited 6×
“This result may be reconciled with cardiomyogenic protocols that employ high levels of Activin-A during Day 0–1 [13,28] by considering that DE cells that are directly induced by this treatment may subsequently induce cardiomyogenesis in indirect fashion [27,29,30], and/or that the effects of Activin-A are context-depe…”
BackgroundMethodResultInfluentialLian, X., Zhang, J., Azarin, S. M., Zhu, K., Hazeltine, L. B., Bao, X., Hsiao, C., Kamp, T. J., & Palecek, S. P. (2013) · Nature Protocols · doi:10.1038/nprot.2012.150 · Cited by 1,748 · cited 2×
“In our experience, induction of Wnt signaling using small MW inhibitors—CHIR and IWP—as described by the Palecek laboratory [8], rather than protein growth factors, most reliably induces cardiomyogenesis (Fig.”
BackgroundMethodEfficient differentiation of human embryonic stem cells to definitive endoderm
D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., & Baetge, E. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1163 · Cited by 1,730
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717 · cited 4×
“As this work was in progress it was reported that low MW organic inhibitors—CHIR and IWP—that modulate Wnt signaling could induce cardiomyogenesis in the absence of exogenous growth factor proteins [7].”
InfluentialHuman cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389 · cited 5×
“3 shows that, consistent with the results described in S2 Fig. as PLOS ONE | DOI:10.1371/journal.pone.0118670 February 23, 2015 10 / 16 well as with previous findings in EBs [17,18], monolayered cells differentiated into either cardiomyocytes or DE as respectively driven by low or high levels of Activin-A.”
BackgroundMethodResultInfluentialHighly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159 · cited 5×
“This result may be reconciled with cardiomyogenic protocols that employ high levels of Activin-A during Day 0–1 [13,28] by considering that DE cells that are directly induced by this treatment may subsequently induce cardiomyogenesis in indirect fashion [27,29,30], and/or that the effects of Activin-A are context-depe…”
BackgroundResultInfluentialBMP4 initiates human embryonic stem cell differentiation to trophoblast
Xu, R.-H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., & Thomson, J. A. (2002) · Nature Biotechnology · doi:10.1038/nbt761 · Cited by 1,128 · cited 1×
“), possibly representing trophoblast cells as previously described [15,16].”
ResultMummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000068356.38592.68 · Cited by 1,001 · cited 1×
“This result may be reconciled with cardiomyogenic protocols that employ high levels of Activin-A during Day 0–1 [13,28] by considering that DE cells that are directly induced by this treatment may subsequently induce cardiomyogenesis in indirect fashion [27,29,30], and/or that the effects of Activin-A are context-depe…”
ResultBasic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R.-H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973 · cited 1×
“It is speculated that positive cardiomyogenic outcomes following treatment with Bmp4 during Days 1–5 [6,13,19,28] reflects, in part, its omission during the first day of induction, and/or the inclusion of bFgf, which antagonizes Bmp during early stages of differentiation [38,39].”
Background
Cited by
Lewis-Israeli, Y. R., Wasserman, A. H., Gabalski, M. A., Volmert, B. D., Ming, Y., Ball, K. A., Yang, W., Zou, J., Ni, G., Pajares, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25329-5 · Cited by 536
Impact of MYH6 variants in hypoplastic left heart syndrome
Tomita‐Mitchell, A., Stamm, K., Mahnke, D. K., Kim, M., Hidestrand, P. M., Liang, H., Goetsch, M. A., Hidestrand, M., Simpson, P. M., Pelech, A. N., et al. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00091.2016 · Cited by 88
“As anticipated (21), MYH7 transcription was first detected on differentiation day 5, at which stage similar levels of MYH7 transcripts were seen in cardiomyocytes representing the proband and its unaffected parent.”
BackgroundMethodInfluentialSelf-citationHuman Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
Brodehl, A., Ebbinghaus, H., Deutsch, M.-A., Gummert, J. F., Gärtner, A., Ratnavadivel, S., & Milting, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184381 · Cited by 78
“, CHIR99021 and IWP2, efficiently increases the differentiation into cardiomyocytes about 90% [344,345].”
BackgroundNg, W. H., Johnston, E. K., Tan, J. J., Bliley, J. M., Feinberg, A. W., Stolz, D. B., Sun, M., Wijesekara, P., Hawkins, F. J., Kotton, D. N., et al. (2022) · eLife · doi:10.7554/elife.67872 · Cited by 47
Kim, M., Fleres, B., Lovett, J. J., Anfinson, M. Q., Samudrala, S. S. K., Kelly, L. J., Teigen, L. E., Cavanaugh, M., Marquez, M., Geurts, A. M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00440 · Cited by 45
“Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 June 2020 | Volume 8 | Article 440 genotype, iPSCs representing WTcc, inserted +/VAR and inserted VAR/VAR were induced to undergo cardiomyogenic differentiation as we previously described (Kim et al., 2015) (depicted in Figure 1B).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Kim, M.-S., Horst, A., Blinka, S., Stamm, K., Mahnke, D., Schuman, J., Gundry, R., Tomita-Mitchell, A., & Lough, J.
- Affiliations
- Medical College of Wisconsin (US)
- Corresponding author
- Lough, John
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-23
- Volume
- 10
- Issue
- 2
- Pages
- e0118670
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4338295
- OpenAlex
- W2085430872
- Cited by
- 38
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 1
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- e-Publications@Marquette (Marquette University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- U.S. Public Health Service (089471)
- National Heart, Lung, and Blood Institute (R00HL094708)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- activin A, BMP4, cardiomyogenesis, Wnt signaling, Nodal signaling, BMP signaling, definitive endoderm, mesoderm specification, cell specification, beating cardiomyocytes, pluripotent cell differentiation
- MeSH terms
- Cell Differentiation, Humans, Sequence Analysis, RNA, Activins, Myocytes, Cardiac, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activin-A and Bmp4 Levels Modulate Cell Type Specification during CHIR-Induced Cardiomyogenesis. https://app.cochat.ai/papers/10.1371/journal.pone.0118670
- The paper
- Kim, M.-S., Horst, A., Blinka, S., Stamm, K., Mahnke, D., Schuman, J., Gundry, R., Tomita-Mitchell, A., & Lough, J. (2015). Activin-A and Bmp4 Levels Modulate Cell Type Specification during CHIR-Induced Cardiomyogenesis. PLOS ONE. https://doi.org/10.1371/journal.pone.0118670
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.